Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer

Autor(en): Dellas, Kathrin
Höhler, Thomas
Reese, Thomas S.
Würschmidt, Florian
Engel, Erik
Rödel, Claus
Wagner, Wolfgang
Richter, Michael
Arnold, Dirk
Dunst, Jürgen
Stichwörter: Internal medicine; Capecitabine; Colorectal cancer; Nausea; Randomized controlled trial; Chemoradiotherapy; Bevacizumab; Medicine; Chemotherapy; Oxaliplatin; Surgery; Gastroenterology; Cancer
Erscheinungsdatum: 2013
Herausgeber: Springer Science+Business Media
Enthalten in: Radiation Oncology
Band: 8
Ausgabe: 1
ISSN: 1748-717X
DOI: https://doi.org/10.1186/1748-717x-8-90
Rechte: cc-by

Zur Langanzeige

Google ScholarTM

Prüfen

Altmetric